Community water fluoridation is considered a significant public health achievement of the 20th century. In this paper, the hypothesis that added water fluoridation has contributed to diabetes incidence and prevalence in the United States was investigated. Panel data from publicly available sources were used with population-averaged models to test the associations of added and natural fluoride on the outcomes at the county level in 22 states for the years 2005 and 2010. The findings suggest that a 1 mg increase in the county mean added fluoride significantly positively predicts a 0.23 per 1,000 person increase in age-adjusted diabetes incidence (P < 0.001), and a 0.17% increase in age-adjusted diabetes prevalence percent (P < 0.001), while natural fluoride concentration is significantly protective. For counties using fluorosilicic acid as the chemical additive, both outcomes were lower: by 0.45 per 1,000 persons (P < 0.001) and 0.33% (P < 0.001), respectively. These findings are adjusted for county-level and time-varying changes in per capita tap water consumption, poverty, year, population density, age-adjusted obesity and physical inactivity, and mean number of years since water fluoridation started. Sensitivity analyses revealed robust effects for both types of fluoride. Community water fluoridation is associated with epidemiological outcomes for diabetes. an ingested additive. The topical effect of fluoride, demonstrated by showing caries reduction, was the result of fluoride acting on the external surface of the teeth, not
INTRODUCTION
Water fluoridation has reportedly produced great benefit to society, often by reducing dental caries and hence the cost that comes with untreated or advanced periodontal disease (Griffin et al. a, b; Jones et al. ) , which may itself often be a trigger of other chronic conditions (Cullinan & Seymour ) . The side effects of water fluoridation have generally appeared to be either inconclusive or minimal Research conducted before and after the widespread implementation of water fluoridation in the 1940s in the United States has suggested that fluoride is a potent preservative of blood glucose (Roe et al. ; Chan et al. ) , thereby inhibiting glycolysis (Halpern ) . Specifically, such glycolytic inhibition from fluoride is thought to mitigate oral bacteria enolase activity (Hüther et al. ) .
Enolase is an enzyme acting late in the glycolytic pathway (Pancholi ) . It is this mechanism which is considered to prevent dental caries, although there has been no general agreement that the anti-microbial effects of fluoride contribute to the anti-caries effect of the chemical (Hamilton ) .
However, one issue that remains is the distinction between fluoride's uses as (1) a topical agent in preventing dental caries (as described above) versus (2) its utility as through ingestion of fluoride itself (Bibby et al. ) . Given the known glycolytic inhibition of sodium fluoride in bacteria, it is plausible that a similar phenomenon could occur in humans. Sodium fluoride that is ingested produced significant decrements in plasma insulin (Rigalli et al. ) , which is known to regulate glycolysis (Wu et al. ) . Furthermore, hypothyroidism, whose deleterious association with water fluoridation was documented above, may be ). Given the profound and growing impacts of diabetes on the American health care system (Seuring et al. ) and the potential for continued adverse side effects from diabetes medications such as dipeptidyl peptidase-4 inhibitors (Food and Drug Administration ), it is worth re-examining the potential influences of fluoride on its prevalence to ensure that all avenues are investigated and, if appropriate, exonerated from further consideration.
After all these years, the question remains unanswered:
to what extent does fluoride predict changes in diabetes outcomes in the United States? The objective of the present study is to robustly examine the associations between added and naturally present fluoride and epidemiological outcomes of diabetes, including prevalence and incidence.
METHODS

Data
To analyze the association between diabetes outcomes and community water fluoridation, data were collected from state fluoridation reports, available in the My Water's Fluoride portal through the Centers for Disease Control and Prevention (CDC a). Although the CDC lists 25 states as having available operational reports, only 22 were accessible via their website. Hence, this investigation focuses on these 22 states, which are identified in Figure 1 .
At the time of access, the state fluoridation reports contained the following variables used in the analysis: (1) water system ID, (2) primary county of the water system, (3) fluoridation chemical (sodium fluoride, fluorosilicic acid, or sodium fluorosilicate), (4) fluoridation start date, (5) natural fluoride level and (6) optimal fluoride level (both in parts per million, ppm). Optimal fluoride level was defined by a range of 0.7-1.2 mg/L (ppm ¼ mg/L) issued in 1962 by the US Department of Health and Human Services (HHS). Every water system independently sets their own optimal level.
Each water system was designated a status regarding water fluoridation; those with a classification of 'adjusted' meant that the level of fluoride in the tap water was manipulated using one of the above listed chemicals to achieve an optimal level.
Other reported statuses included 'non ', 'nat', or 'cons'. 'Non' status referred to water systems with an insufficient natural fluoride level (<0.7 mg/L) but no fluoridation chemical identified to achieve optimal status; 'nat' status generally denoted water systems with a sufficient natural fluoride level (!0.7 mg/L); 'cons' status identified water systems with missing information for both the natural fluoride concentration and chemical used.
To these list, several additional variables were generated.
The five-digit Federal Information Processing Standard (FIPS) code was inserted, which uniquely identifies counties and county equivalents, to facilitate (1) the averaging of natural and optimal levels of fluoride concentrations by county and (2) the merging with other CDC data. The natural and optimal fluoride levels, defined by the water system, were averaged by county. All data available on natural fluoride concentrations (i.e. using water systems with 'adj', 'non' or 'nat' status) were used to produce a county average for natural fluoride. To calculate the average added levels for each county, only water systems with an adjusted status where fluoridation chemicals could be identified were used. To calculate the mean added fluoride concentration, the mean natural level was subtracted from the mean optimal level for the county. Similarly, the criterion for defining the fluoridation chemical was the type of additive used by a water system in a county with an adjusted status. Thus a county could be identified as using all three chemicals if at least three different water systems in the county with an adjusted status used each chemical. A mean 'years fluoridated' variable was also defined, which was computed as the number of years before December 31, 2004 and December 31, 2009 that a water system was fluoridated, averaged over the county. A negative outcome here suggested that water fluoridation started after these dates. The 'years fluoridated' variable also only reflects the average among water systems in a county with an adjusted status.
The most recent fluoridation start date provided among all water systems in the 22 states identified was January 2011. This was interpreted as the last date of update for these data. Hence, the scope of our analyses was limited to the complete calendar year 2010 and the years prior.
To these fluoride data, other covariates were added that reflected our outcomes and other relevant predictors. These and 2010 for all counties. For each FIPS code, a ratio was created, dividing domestic deliveries per county in millions of liters per day by total people supplied to get a per capita water delivery. The USGS estimates that an individual uses 302.8-378.5 L of water a day. It was estimated that each individual drinks 1.9 L of water a day. Dividing 1.9 L by 302.8 (≈0.625%) and 378.5 (¼0.5%) liters yields an approximate range of the proportion of the per capita supply that is actually ingested. Multiplying per capita water consumption in liters by 0.625% provides the upper limit (UL) on the water supply that is ingested, whereas multiplying by 0.5% gives the lower limit (LL). The resulting products are estimates in liters of water. Converting these per capita outcomes for water intake to liters and multiplying by the (added or natural) fluoride exposure in milligrams per liter averaged by county gives the unit of measurement for the fluoride covariates in terms of milligrams. For comparison, exposure where the fluoride concentration is unadjusted for per capita tap water consumption was also considered. Thus, there were two sets of regressions for the diabetes outcomes: the aforementioned analysis with the primary exposure in milligrams (mg) and an alternative, unadjusted analysis with the primary exposure in ppm.
Regression analyses
In accordance with the research inquiries, two sets of regressions were composed using generalized estimating equations (GEE) population-averaged models using autore- and are specified as the following: All analyses were completed with Stata 11.1 (StataCorp ). The significance of variables was indicated with P < 0.05, but also reported for lower significance thresholds (P < 0.01, P < 0.001) where appropriate. No ethics approval was required for the study, given its exclusive reliance on publicly accessible data. Figure 1 this suggests that investigation of the impact of water fluoridation on diabetes outcomes using these data is sufficient to determine the association. Thus, in the last two decades, the growth in diabetes has been on a mostly linear trajectory, which has been confirmed in a recent study on comorbidities including diabetes among Table 2 ). were reported. 658 water systems in 116 counties did not have data on optimal fluoridation level. The effect of added fluoride on incidence was slightly greater than half the effect of age-adjusted obesity prevalence (β ¼ 0.31, P < 0.001), which suggests that a 1% increase in the obesity prevalence for an average county drives incidence up by 0.31 per 1,000 persons as compared to a county not experiencing a comparable increase in obesity prevalence.
RESULTS
The coefficient for year indicates that the incidence of diabetes declined in the selected states from 2005 to 2010 (β ¼ -1.85, P < 0.001). Finally, the type of fluoridation chemical used may also make a significant difference in diabetes incidence. Among the three used in this data set, fluorosilicic acid was most significantly associated with reduced diabetes incidence (β ¼ -0.45, P < 0.001), inducing the greatest decline in incidence apart from the year variable.
The results for the E ¼ 2 models with age-adjusted diabetes prevalence percent as the outcome largely mirrored the incidence models, with a notable exception for the year variable, which now produced a positive effect (β ¼ 0.33, P < 0.001). Importantly, the results for the added fluoride concentration (β ¼ 0.17, P < 0.01) and fluorosilicic acid (β ¼ -0.33, P < 0.001) were mostly unchanged.
Fluoridation chemical is included as a confounder in the S ¼ 2 models, but it could be an effect modifier rather than a per 1,000 increase in diabetes incidence (P < 0.001) and a 0.27% increase in prevalence (P < 0.001), whereas the respective estimates for natural fluoride were 0.73 per 1,000 decline (P < 0.001) and a 0.55% decline (P < 0.001).
The counterintuitive findings for significance and sign of the 'years water system fluoridated' between the M ¼ 1 and M ¼ 2 models was noted. There was a low (but significant) and negative correlation (rho ¼ À0.18, P < 0.001) between the average years a county's water supply has been fluoridated and per capita consumption of tap water in that county. It appears that the negative parameter estimates may be the result of a selection issue (the longer a water system is fluoridated, the more migration to alternative water sources may be occurring). Given the significance disappears when the per capita tap water consumption component is integrated into the models suggests this may be the case. Table 5 displays the sensitivity results from the combined exposures. In 32 counties, the mean quantity of natural fluoride was greater than the mean optimal level.
In these cases, the added fluoride concentration was negative, which might confound any protective effect of the natural fluoride concentration seen in the analyses thus far. Therefore, these 64 county-year observations were removed and the GEE analyses re-run for both outcomes in the sensitivity analyses. For the M ¼ 1 models, the results coincided with those presented in Tables 3 and 4. That is, added fluoride exerted a positive and significant change on incidence (0.26 per 1,000 increase) and prevalence (0.22% increase), whereas natural fluoride exhibited a protective effect (0.45 per 1,000 decrease and 0.32% decline, respectively). For the M ¼ 2 model set, however, both exposures demonstrated negative relationships, with the effect of natural fluoride (3.12 per 1,000 decline in incidence and 2.3% reduction in prevalence) being about twice that of added fluoride (1.68 per 1,000 decrease in incidence and 1.09% decline in prevalence). Thus, the sensitivity analyses showed that only the adjusted exposures (using milligrams to account for per capita tap water consumption) revealed robustly consistent associations with diabetes outcomes.
DISCUSSION
In this report, the relationship between added fluoride and diabetes in 22 states using population-averaged models was examined, which revealed the following main findings:
1. Fluoride added to achieve optimal levels (defined as between 0.7-1.2 ppm) was significantly positively and robustly associated with increases in both the incidence and prevalence of diabetes from 2005 to 2010 when accounting for per capita consumption of tap water.
2. Among the three fluoridation chemicals used in this data set (sodium fluoride, fluorosilicic acid, or sodium fluorosilicate), only fluorosilicic acid was significantly and robustly associated with decreases in incidence and prevalence of diabetes.
The first main finding is valuable because of the adjustment for per capita tap water consumption, whereas the second is useful in discriminating between similar yet dis- (Table 5) suggests that within a 5-year span, the incidence of diabetes could increase by up to 0.88 per 1,000 persons and prevalence may grow by as much as 0.85% as a consequence of water fluoridation alone. However, these are likely liberal estimates, since the IOM makes no distinction between added and natural fluoride as done in the present analysis.
The differences present in the combined estimates for adjusted (M ¼ 1 model) versus unadjusted (M ¼ 2 model) Number of observations 1,518 1,518 1,518 1,518
Robust standard errors in parentheses. ***P < 0.001, **P < 0.01, *P < 0.05. Covariates Incidence Prevalence Incidence Prevalence There are several limitations to this work. First, it is difficult to unequivocally state that these results are the specific consequences of water fluoridation. This is for two reasons.
Although 
